India’s Diabetes Care Must Go Beyond Blood Sugar, Doctors Say

The Story in Brief

More than 100 million Indian adults live with type 2 diabetes, and the number could exceed 150 million by 2050, Times Now reports, citing International Diabetes Federation projections. Doctors say treatment must address risks to the heart, kidneys, nerves and eyes, not glucose levels alone. The report says only one in 10 people with diabetes in India meet recommended blood sugar targets. It also describes GLP-1 receptor agonists, which can improve glucose control, support weight management and, in suitable patients, reduce cardiovascular risk and protect kidney function. Doctors stress that prescribing must be individualised and medicines must meet rigorous manufacturing and clinical standards.

The Indian Opinion

The loudest narrative is that a newer injection can solve diabetes, while another treats blood sugar control as the whole job. Both are too simple. GLP-1 medicines may help some patients, but they are not a substitute for diagnosis, diet, activity, monitoring or medical advice. Claims about heart and kidney benefits also depend on the specific drug and patient. The useful test is whether care improves the share of Indian patients reaching safe targets, beyond the reported one in 10.

Source: timesnownews.com

This story was synthesised by AI from the source linked above.

Ask their opinion on this story

They have read this article, our coverage, and the web.

Rabindranath TagoreGandhiMuhammad Ali JinnahB. R. AmbedkarJawaharlal NehruVinayak Damodar SavarkarSubhas Chandra Bose

AI simulations of historical figures. Responses are generated from the historical record, not authentic statements.